Benzinga · Nov 13, 2026
JP Morgan Maintains Overweight on Corteva, Lowers Price Target to $16
JP Morgan analyst Jeffrey Zekauskas maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $19 to $16.

NASDAQ · CTVA
Basic Materials · Agricultural Inputs
$9.43
Up+$0.24 (+2.61%)
Updated Nov 15, 2026, 7:07 AM
SID Score
5.2/10
Composite research score
Smart Money
47/100
Neutral
Price performance · CTVA
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
CTVA closed at $9.43 after 20 trading sessions, down 25.45% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $9.11 | $9.495 | $9.0104 | $9.43 | 28.9M |
| Nov 12, 2026 | $10.51 | $10.69 | $9.14 | $9.19 | 64.97M |
| Nov 11, 2026 | $12.12 | $12.235 | $11.895 | $12.14 | 13.35M |
| Nov 10, 2026 | $12.02 | $12.355 | $11.84 | $12.17 | 11.62M |
| Nov 9, 2026 | $12.00 | $12.405 | $11.87 | $12.11 | 24.12M |
| Nov 6, 2026 | $11.90 | $12.07 | $11.78 | $11.90 | 26.44M |
| Nov 5, 2026 | $12.40 | $12.68 | $11.81 | $12.04 | 16.35M |
| Nov 4, 2026 | $12.025 | $12.34 | $11.70 | $12.26 | 32.55M |
| Nov 3, 2026 | $11.85 | $12.03 | $11.72 | $11.88 | 19.73M |
| Nov 2, 2026 | $11.61 | $12.02 | $11.51 | $11.92 | 20.39M |
| Oct 30, 2026 | $11.53 | $11.755 | $11.435 | $11.64 | 30.78M |
| Oct 29, 2026 | $11.36 | $11.53 | $11.315 | $11.47 | 22.43M |
| Oct 28, 2026 | $11.63 | $11.73 | $11.245 | $11.33 | 21.87M |
| Oct 27, 2026 | $11.93 | $12.115 | $11.62 | $11.63 | 16.41M |
| Oct 26, 2026 | $12.48 | $12.54 | $11.89 | $11.95 | 15.68M |
| Oct 23, 2026 | $12.67 | $12.74 | $12.38 | $12.45 | 14.71M |
| Oct 22, 2026 | $12.58 | $12.89 | $12.52 | $12.86 | 16M |
| Oct 21, 2026 | $12.86 | $12.91 | $12.505 | $12.72 | 18.63M |
| Oct 20, 2026 | $12.63 | $13.035 | $12.60 | $12.90 | 13.5M |
| Oct 19, 2026 | $12.85 | $13.005 | $12.50 | $12.65 | 23.94M |
The latest Smart Investors Daily articles mentioning CTVA.
Company
Market Activity
Research & News
CTVA research
Company profile and research snapshot.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 13, 2026 | UBS | Neutral | — |
| Nov 13, 2026 | JP Morgan | Overweight | — |
| Nov 13, 2026 | RBC Capital | Outperform | — |
| Nov 13, 2026 | Citigroup | Neutral | — |
| Oct 12, 2026 | UBS | Neutral | — |
No generated briefing is available yet.
Benzinga · Nov 13, 2026
JP Morgan analyst Jeffrey Zekauskas maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $19 to $16.
Yahoo · Nov 13, 2026
CTVA cuts its 2026 profit outlook as Brazil's inventory glut and pricing pressures weigh on results, while new products and cost cuts support recovery plans.
Benzinga · Nov 13, 2026
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.
Benzinga · Nov 13, 2026
RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CTVA.